Engineering irradiated tumor-derived microparticles as personalized vaccines to enhance anti-tumor immunity
Description
The inadequate activation of antigen-presenting cells, the entanglement of T cells, and the highly immunosuppressive conditions in the tumor microenvironment (TME) are important factors that limit the effectiveness of cancer vaccines. Studies show